Flavobacterium psychrophilum is one of the most important pathogens affecting cultured 32 rainbow trout (O. mykiss). Recent information from UK salmonid farms showed country-wide 33 distribution of genetically and serologically divergent clones which has hampered the 34 development of a vaccine for Rainbow Trout Fry Syndrome. The current study assessed the 35 efficacy of an injectable polyvalent vaccine containing formalin-inactivated F. psychrophilum 36 in rainbow trout. The vaccine was formulated with an oil adjuvant (Montanide ISA 760VG) 37 or formalin killed cells alone. Duplicate groups of trout (60 ± 13 g) were given phosphate 38 buffered saline or vaccine formulated with Montanide by intraperitoneal (i.p.) injection and 39 challenged by intramuscular (i.m.) injection with a homologous and a heterologous isolate of 40 F. psychrophilum at 525 degree days post-vaccination (dd pv). Significant protection was 41 achieved in vaccinated fish (p=0.0001, RPS 76% homologous, 88% heterologous). Efficacy 42 of the adjuvanted vaccine was also demonstrated by heterologous challenge at 1155 dd pv 43 resulting in 100% protection, whereas survival in the un-adjuvanted group was not 44 significantly different from control fish. Levels of specific antibody at 1155 dd pv, as 45 measured by ELISA, were significantly higher in the fish vaccinated with adjuvant when 46 compared with unvaccinated fish. 47 48 49
inflammatory reactions followed by a specific systemic immune response (Fredriksen et al., 78 2013 ). 79
The current study was performed to assess the efficacy of a polyvalent, whole cell injectable 80 vaccine containing formalin-inactivated F. psychrophilum, with and without adjuvant 81 (mineral oil, Montanide™) to induce protective immunity in rainbow trout (60 g) against the 82 pathogen. Protection against a homologous and a heterologous strain was investigated in trout 83
at 525 dd and efficacy of the vaccine against a heterologous isolate at 1155 dd (nearly twice 84 that recommended by most vaccine manufacturers for induction of immunity to bacterial 85 antigens). Immune responses in vaccinated and unvaccinated trout were investigated pre-86 challenge by ELISA and Western blot. 87 88 2 Materials and Methods 89
Rainbow trout 90
Rainbow trout eggs were supplied by AquaGen (Norway) and transported on ice to the 91 aquarium at the Institute of Aquaculture, University of Stirling. On arrival, the eggs were 92 subjected to iodophor surface disinfection according to the manufacturer's instructions 93 (Buffodine, Evans Vanodine, UK). Five replicates of 10 eggs were removed and confirmed to 94 be F. psychrophilum-free using a nested PCR that targets the 16S rRNA gene (Ngo et al., 95 2017; Toyama, Kita-Tsukamoto, & Wakabayashi, 1994). The eggs were maintained in flow-96 through de-chlorinated tap water at 10ºC until hatch, and thereafter maintained in a 100 L 97 flow-through tank (5 L min -1 ). Fry were fed to satiation daily (Inicio feed, 1.1 mm, BioMar, 98 UK). All experimental procedures with live fish were carried out in accordance with the UK 99 Animals (Scientific Procedures) Act, 1986 and associated guidelines (EU Directive 100 2010/63/EU) and were approved by the Ethics Committee of the University of Stirling. 101
Preparation of formalin inactivated bacteria 103
Two isolates of F. psychrophilum recovered from trout and one recovered from Atlantic 104 salmon in the UK in 2013 were used to make a formalin killed whole cell vaccine (FKC) 105 (AVU-1T/13, serotype Fd; AVU-2T/13, serotype Th; and AVU-3S/13, serotype FpT; ) as 106 described previously (Hoare et al., 2017) . The three cultures were mixed in equal parts to 107 form the whole cell vaccine at a final concentration of 1 × 10 9 colony forming units (CFU) 108 mL−1. 109 110
Preparation of vaccine formulations and vaccination 111
The formalin-inactivated vaccine prepared above, was emulsified with Montanide 760VG 112 (Seppic, France) (Montanide70:FKC30) and stored at 4 ºC. Stability of the emulsion was 113 examined macro and microscopically for a 7 day period following emulsification. 114
Fish (60 g ± 13) were randomly separated into 100 L flow-through tanks with aeration at 115 15ºC. The experimental design of the vaccination trials is summarised in Table 1 . As previous 116 studies have shown no protection after challenge when adjuvant alone is administered 117 (Fredriksen et al., 2013), an adjuvant-alone group was excluded from this study. Fish were 118 anaesthetised with benzocaine (Sigma, 0.004%) and vaccinated by i.p. injection (50 µl/fish). 119
Control groups were injected i.p. with 50 µl/fish of sterile phosphate buffered saline (PBS). 120
Prior to challenge (525 dd and 1155 dd pv) fish were anaesthetised with benzocaine (as 121 above) and blood was sampled from the caudal vein using a 23 G needle and syringe from 122 three fish per duplicate group (n= 6) stored overnight at 4ºC, centrifuged for 5 min at 3000 x g 123 for collection of serum, and stored at -20ºC until analysis. 124
Dose response studies were conducted to determine the lethal dose 60 % (LD60) for each 127 isolate (data not shown). Challenge was conducted with both a homologous strain (AVU-128 2T13; 1.3 x 10 7 colony forming units (CFU/fish) and a heterologous strain of F. Montanide exhibited a significantly higher average titre of 144 (n= 4, p = 0.04) ( Table 2) . 216 217
SDS-PAGE and Western blot 218
Distinct bands ranging from 10-100 kDa were evident in the SDS-PAGE profiles of the F. 219 psychrophilum strains used to prepare the polyvalent vaccine (and a heterologous strain AVU-1T/07) following staining of gels with Coomassie ( Figure 4a ). The banding profiles of the 221 strains were similar with a slightly lower weight band occurring in the heterologous strain 222 between 20-25 kDa. In Western blotting, stronger staining was evident when F. 223 psychrophilum isolates were screened with serum from the fish vaccinated with FKC and 224
Montanide (Figure 4b (iii) ) compared to that seen with serum of unvaccinated (Figure 4b 
